Thompson Siegel & Walmsley LLC Buys Shares of 929 Axon Enterprise, Inc. (NASDAQ:AXON)

Thompson Siegel & Walmsley LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 929 shares of the biotechnology company’s stock, valued at approximately $273,000.

A number of other large investors have also made changes to their positions in AXON. Vanguard Group Inc. grew its position in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares during the period. Sands Capital Management LLC grew its holdings in shares of Axon Enterprise by 0.6% in the 4th quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after acquiring an additional 16,347 shares during the period. Norges Bank acquired a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $195,406,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 5.1% in the 4th quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after purchasing an additional 35,528 shares in the last quarter. Finally, Motley Fool Asset Management LLC raised its holdings in Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock worth $153,981,000 after purchasing an additional 346,838 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on AXON shares. Bank of America initiated coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price on the stock. Barclays raised their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Northland Securities upped their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Craig Hallum raised their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group initiated coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $365.38.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the sale, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brittany Bagley sold 4,338 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The disclosure for this sale can be found here. Insiders have sold a total of 316,981 shares of company stock valued at $115,281,744 over the last quarter. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $385.77 on Tuesday. The stock has a fifty day moving average price of $340.58 and a 200 day moving average price of $315.24. Axon Enterprise, Inc. has a 52 week low of $189.12 and a 52 week high of $386.54. The firm has a market capitalization of $29.15 billion, a P/E ratio of 112.80, a PEG ratio of 10.30 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the company posted $0.80 EPS. The company’s quarterly revenue was up 34.5% compared to the same quarter last year. Equities research analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.